Formulation and Characterization of Nanoparticulate Drug Carrier System for Lacidipine

Dessai, Ashveta Anant; Kantak, Mrunali Navin; DCruz, Cleona Elizabeth Mary; Kumar, Lalit; Bhide, Prashant Jivaji; Shirodkar, Rupesh Kalidas

doi:10.1089/adt.2023.023

ASSAY and Drug Development Technologies

2023

DOI: 10.1089/adt.2023.023

|View full text |Cite

Formulation and Characterization of Nanoparticulate Drug Carrier System for Lacidipine

Ashveta Anant Dessai,

Mrunali Navin Kantak,

Cleona Elizabeth Mary DCruz

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Formulation of Felodipine lipid nanoparticle-loaded oral fast-dissolving films

Naik,

DCruz,

Kumar

et al. 2024

Tenside Surfactants Detergents

View full text Add to dashboard Cite

Felodipine, a calcium channel blocker used to treat hypertension, is a BCS Class II drug characterized by low solubility, high permeability and significant hepatic metabolism, which limits its bioavailability to 15 %. This study focuses on improving the bioavailability of Felodipine by developing oral fast-dissolving films (OFDFs) incorporating lipid nanoparticles. Felodipine loaded lipid nanoparticles were prepared using glyceryl monooleate (GMO) as lipid and Poloxamer 407 as the surfactant, and then incorporated into OFDFs using the solvent casting technique. A Box-Behnken design with Design Expert Stat-Ease® 360 was used to evaluate the impact of GMO, Poloxamer 407 concentration, and sonication time on particle size and entrapment efficiency. The resulting nanoparticle dispersions had particle sizes ranging from 74.92 nm to 112.1 nm and entrapment efficiencies between 80.43 % and 95.23 %. Differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), and X-ray diffraction (XRD) confirmed successful drug encapsulation. The OFDF showed optimal mechanical properties, disintegration within (41.33 ± 3.51) s, and an in-vitro drug release of (89.82 ± 2.75) % in 6 min. Scanning electron microscopy (SEM) revealed a smooth, uniform, porous surface and the films remained stable for three months. The study concludes that Felodipine loaded lipid nanoparticles in fast-dissolving OFDFs improve permeability, dissolution, and onset of action, making them a promising approach for antihypertensive therapy.

show abstract

Formulation of Felodipine lipid nanoparticle-loaded oral fast-dissolving films

Naik,

DCruz,

Kumar

et al. 2024

Tenside Surfactants Detergents

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Formulation and Characterization of Nanoparticulate Drug Carrier System for Lacidipine

Cited by 1 publication

References 29 publications

Formulation of Felodipine lipid nanoparticle-loaded oral fast-dissolving films

Formulation of Felodipine lipid nanoparticle-loaded oral fast-dissolving films

Contact Info

Product

Resources

About